|
2009
|
Invention
|
Modulators of amyloid aggregation.
Compounds that modulate the aggregation of amyloidogenic prot... |
|
|
Invention
|
2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase i... |
|
2008
|
Invention
|
Methionine aminopeptidase-2 inhibitors and methods of use thereof.
The present invention provide... |
|
2007
|
Invention
|
Methods for treating mitf associated diseases by the use of methionine aminopeptidase-2 inhibitor... |
|
|
Invention
|
S1p-1 receptor agonists.
The invention provides compounds formula (I), their preparation, and th... |
|
|
Invention
|
Chemical compounds. The invention provides compounds formula (I), their preparation, and their us... |
|
|
Invention
|
Agonists of the sphingosine-1 phosphate receptor.
The invention provides compounds formulae I-II... |
|
|
Invention
|
Agonists of the sphingosine-1-phosphate receptor. The invention provides compounds formulae I-III... |
|
|
Invention
|
Agonists of sphingosine-1 phosphate receptor (slp).
The invention provides compounds of formula ... |
|
|
Invention
|
Chemical compounds.
The invention provides compounds formula I, their preparation, and their use... |
|
|
Invention
|
Chemical compounds.
The invention provides compounds of formula I and formula II, their preparat... |
|
|
Invention
|
Agonists of the sphingosine- 1- phosphate receptor (slp). The invention provides compounds of for... |
|
|
Invention
|
Chemical compounds. The invention provides compounds formula I, their preparation, and their use ... |
|
|
Invention
|
P38 kinase inhibitors. Compounds of formula (I) and (Il) are disclosed, as well as methods for th... |
|
|
Invention
|
Aurora kinase inhibitors from an encoded small molecule library. The present invention provides, ... |
|
|
Invention
|
Methionine aminopeptidase-2 inhibitors and methods of use thereof. The present invention provides... |
|
|
Invention
|
Methods and compositions for modulating sphingosine -1- phosphate (s1p) receptor activity.
The p... |
|
|
Invention
|
Compositions, kits, and methods for identification, assessment, prevention, and therapy of endome... |
|
|
Invention
|
Methods for treating bone associated diseases by the use of methionine aminopeptidase-2 inhibitor... |
|
|
Invention
|
Methods for assessing the efficacy of treatment with a glucocorticoid. The invention relates to m... |
|
|
Invention
|
Methods for assessing the efficacy of treatment with a glucocorticoid.
The invention relates to ... |
|
|
Invention
|
Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity. The pres... |
|
|
Invention
|
Methods and compositions for treating inflammatory disorders.
The present invention provides met... |
|
2006
|
Invention
|
Therapeutic agents and methods of use thereof for the modulation of angiogenesis.
The present in... |
|
|
Invention
|
Methods for identifying compounds of interest using encoded libraries. The present invention prov... |
|
|
Invention
|
Methods for treating hormone associated conditions using a combination of lhrh antagonists and sp... |
|
|
Invention
|
Pharmaceutical formulations for sustained drug delivery. Sustained delivery formulations comprisi... |
|
|
Invention
|
Pharmaceutical formulations for sustained release. Sustained delivery pharmaceutical compositions... |
|
|
Invention
|
Pharmaceutical formulations for sustained drug delivery. The present invention provides pharmaceu... |
|
|
Invention
|
Stable pharmaceutical formulations and methods of use thereof. The present invention provides pha... |
|
|
Invention
|
Methods for synthesis of encoded libraries. The present invention provides a method of synthesizi... |
|
|
Invention
|
Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity.
The pre... |
|
|
Invention
|
Methods for treating fsh related conditions with gnrh antagonists.
Methods for treating FSH rela... |
|
2005
|
Invention
|
Pharmaceutical formulations for sustained drug delivery.
Sustained delivery formulations compris... |
|
|
Invention
|
Pharmaceutical formulations for sustained release.
Sustained delivery pharmaceutical composition... |
|
|
Invention
|
Pharmaceutical formulations for sustained drug delivery.
The present invention provides pharmace... |
|
|
Invention
|
Methods for treating long qt syndrome.
The present invention provides compositions and methods f... |
|
2004
|
Invention
|
Inhibitors of methionine aminopeptidase-2 and uses thereof.
The instant invention provides compo... |
|
|
Invention
|
Inhibitors of methionine aminopeptidase-2 and uses thereof. The instant invention provides compos... |
|
2003
|
Invention
|
Modulators of β-amyloid peptide aggregation comprising d-amino acids. 17-21. In certain embodimen... |
